Yantai North Andre Juice (605198.SH): Guangzhou Uni President plans to reduce its shareholding by no more than 1%
Andeli (605198.SH) announced that Guangzhou Unity plans to reduce its holdings of the company's shares through centralized bidding by not more than 3.412 million shares, or not more than 1% of the total share capital. The reduction period will be within 3 months after 15 trading days from the announcement date. The reduction price will be determined based on market prices.
Yantai North Andre Juice (605198.SH) announced that Guangzhou Unification plans to reduce its holdings of the company's shares by no more than 3.412 million shares, or 1% of the total share capital, through centralized bidding. The reduction period is within 3 months after 15 trading days from the date of the announcement. The reduction price will be determined based on the market price.
Related Articles
HAOHAI BIOTEC (06826) spent 837,000 Hong Kong dollars to repurchase 30,500 shares on December 5th.
The controlling shareholder of KONTA CHINA (01312) remains unchanged. Shanxi Construction Investment holds 52.44% of the shares and Shanxi Communications holds 90% of the shares have been transferred to the Shanxi Provincial State-owned Assets Supervision and Administration Commission.
CSPC PHARMA (01093): GLP-1/GIP receptor biased agonist dual peptide injection approved for clinical trials in the United States.
HAOHAI BIOTEC (06826) spent 837,000 Hong Kong dollars to repurchase 30,500 shares on December 5th.
The controlling shareholder of KONTA CHINA (01312) remains unchanged. Shanxi Construction Investment holds 52.44% of the shares and Shanxi Communications holds 90% of the shares have been transferred to the Shanxi Provincial State-owned Assets Supervision and Administration Commission.
CSPC PHARMA (01093): GLP-1/GIP receptor biased agonist dual peptide injection approved for clinical trials in the United States.
